SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 378.04 |
| Enterprise Value ($M) | 250.48 |
| Book Value ($M) | 250.50 |
| Book Value / Share | 1.11 |
| Price / Book | 1.51 |
| NCAV ($M) | -89.71 |
| NCAV / Share | -0.40 |
| Price / NCAV | -4.21 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.76 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.54 |
| Current Ratio | 3.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 160.81 |
| Assets | 501.02 |
| Liabilities | 250.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -271.47 |
| Net Income | -266.76 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -223.15 |
| Cash from Investing | 17.45 |
| Cash from Financing | 199.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 4.81 | -18.48 | |
| 13G/A | ARCH Venture Fund IX, L.P. | 20.60 | 4.27 | |
| 13G/A | Canada Pension Plan Investment Board | 4.60 | 0.00 | |
| 13G/A | Fmr Llc | 14.21 | 42.59 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 | |
| 13G/A | Baillie Gifford & Co | 4.70 | 2.07 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,625,377 | 3,464,475 | 46.92 | |
| 2,387,430 | 5,938,830 | 40.20 | |
| 1,047,270 | 2,499,113 | 41.91 | |
| 1,200,053 | 2,992,281 | 40.10 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RPTX – Repare Therapeutics Inc. | RVMD – Revolution Medicines, Inc. |
| RXRX – Recursion Pharmaceuticals, Inc. | SCPH – scPharmaceuticals Inc. |
| SDGR – Schrödinger, Inc. |
Financial data and stock pages provided by
Fintel.io